TFAP2C and bladder transitional cell carcinoma: A correlation analysis of disease-free survival time with WWOX, TFAP2C and TFAP2A levels revealed that in BLCA patients the most favorable is high WWOX expression with simultaneously low TFAP2C and TFAP2A (Fig. 6b, group D).